Trials / Conditions / Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8
Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8
4 registered clinical trials studyying Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Chemoradiation and Pembrolizumab Followed by Pembrolizumab and Lenvatinib Before Surgery for the Treatment of NCT04929392 | City of Hope Medical Center | Phase 2 |
| Active Not Recruiting | Testing the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advance NCT04391049 | NRG Oncology | Phase 1 |
| Completed | Use of Trifluridine/Tipiracil and Oxaliplatin as Induction Chemotherapy for the Treatment of Resectable Esopha NCT04097028 | Roswell Park Cancer Institute | Phase 2 |
| Active Not Recruiting | Phase I/II Study of Perioperative Chemotherapy Plus Immunotherapy Followed by Surgery in Localized Esophageal NCT03784326 | M.D. Anderson Cancer Center | Phase 2 |